Ligand profile
ZINC3830511
Virtual-screening candidate from ZINC.
Bound to: VK055_4127 — phosphoglycerate kinase family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC3830511- UniProt (similar protein)
P07378- Tanimoto
- 0.841
- Target protein
- VK055_4127
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 125.9
- −1 ≤ LogP ≤ 5 0.48
- MW ≤ 500 Da 423.5
- LogP ≤ 5 0.48
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 125.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)CSc3ccncc3)[C@H]2SC1
InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1
UQLLWWBDSUHNEB-CZUORRHYSA-NUQLLWWBDSUHNEB-CZUORRHYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL1201043
- Homolog
- P07378
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC3830511 →
- ZINC ZINC20 ZINC3830511 →
- UniProt UniProt P07378 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC3830511”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4127.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).